The Information reported on 18 August that Anthropic has been preparing a class of stock giving chief executive Dario Amodei and other co-founders additional voting power ahead of a listing. Reuters carried the report the same evening. Anthropic did not comment.

What is actually reported

It would be the first time Anthropic's leadership held extra voting power. Amodei is said to own about 2% of the company. The report rests on two people familiar with the matter, and carries an unusually explicit hedge: "The specifics of the voting arrangements could not be learned, and the plans could still change." An IPO is expected later this year and is described as potentially one of the largest market debuts on record.

What the common telling gets wrong

The headline version — "Anthropic grants Amodei supervoting shares" — is wrong in every element. Nothing has been granted. There is no filing, no S-1, no confirmation and no disclosed ratio. A second error inverts the mechanism: this is not Amodei seizing control from the governance structure. Anthropic's Long-Term Benefit Trust retains a special class of stock that elects a majority of the board, and that arrangement is being kept. Founder supervoting stacks on top of a layer the founders do not personally control. And the 2% is not the scandal — it is the explanation. A chief executive holding roughly a fiftieth of the company has no ordinary route to influence after a listing, which is precisely when supervoting stock becomes the standard instrument.

The comparison being drawn

The wire copy reaches for Meta, where Mark Zuckerberg holds roughly 60% voting control through supervoting shares. That is a useful ceiling rather than a forecast: no reported figure puts Anthropic's proposed arrangement anywhere near it, because no figure has been reported at all.

Why the structure is the story

Anthropic's public-benefit-corporation form plus the trust was the thing it pointed to when arguing it was governed differently from its competitors. Bolting founder supervoting stock on before a listing is the first hard test of how that structure survives contact with public markets — and, if it happens, the template every other lab's pre-IPO governance gets measured against.